243 related articles for article (PubMed ID: 27113429)
21. Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial.
Bath-Hextall F; Ozolins M; Armstrong SJ; Colver GB; Perkins W; Miller PS; Williams HC;
Lancet Oncol; 2014 Jan; 15(1):96-105. PubMed ID: 24332516
[TBL] [Abstract][Full Text] [Related]
22. Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
Jansen MHE; Kessels JPHM; Nelemans PJ; Kouloubis N; Arits AHMM; van Pelt HPA; Quaedvlieg PJF; Essers BAB; Steijlen PM; Kelleners-Smeets NWJ; Mosterd K
N Engl J Med; 2019 Mar; 380(10):935-946. PubMed ID: 30855743
[TBL] [Abstract][Full Text] [Related]
23. Long-Term Efficacy of Photodynamic Therapy with Fractionated 5-Aminolevulinic Acid 20% versus Conventional Two-Stage Topical Methyl Aminolevulinate for Superficial Basal-Cell Carcinoma.
van Delft LCJ; Nelemans PJ; Kessels JPHM; Kreukels H; Roozeboom MH; de Rooij MJM; Mosterd K; de Haas ERM; Kelleners-Smeets NWJ
Dermatology; 2022; 238(6):1044-1049. PubMed ID: 35598594
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
[TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome.
Jerjes W; Hamdoon Z; Hopper C
Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314
[TBL] [Abstract][Full Text] [Related]
26. Comparing Topical Treatments for Basal Cell Carcinoma.
Shaw FM; Weinstock MA
J Invest Dermatol; 2018 Mar; 138(3):484-486. PubMed ID: 29395168
[TBL] [Abstract][Full Text] [Related]
27. Commentary on 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial'.
Nijsten T
Br J Dermatol; 2015 Jan; 172(1):12. PubMed ID: 25581586
[No Abstract] [Full Text] [Related]
28. Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Requena C; Messeguer F; Llombart B; Serra-Guillén C; Guillén C
Int J Dermatol; 2012 Apr; 51(4):451-4. PubMed ID: 22435437
[TBL] [Abstract][Full Text] [Related]
29. Response to 'Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial: a critical appraisal'.
Arits A; Nelemans P; Kelleners-Smeets N
Br J Dermatol; 2015 Jan; 172(1):11-2. PubMed ID: 25581585
[No Abstract] [Full Text] [Related]
30. Er:YAG ablative fractional laser-primed photodynamic therapy with methyl aminolevulinate as an alternative treatment option for patients with thin nodular basal cell carcinoma: 12-month follow-up results of a randomized, prospective, comparative trial.
Choi SH; Kim KH; Song KH
J Eur Acad Dermatol Venereol; 2016 May; 30(5):783-8. PubMed ID: 26551044
[TBL] [Abstract][Full Text] [Related]
31. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P
Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375
[TBL] [Abstract][Full Text] [Related]
32. Methyl aminolevulinate photodynamic therapy after partial debulking in the treatment of superficial and nodular basal cell carcinoma: 3-years follow-up.
Gómez C; Cobos P; Alberdi E
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102176. PubMed ID: 33429099
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature.
Drehs MM; Cook-Bolden F; Tanzi EL; Weinberg JM
Dermatol Surg; 2002 May; 28(5):427-9. PubMed ID: 12030878
[TBL] [Abstract][Full Text] [Related]
34. Two-year interim results from a 5-year study evaluating clinical recurrence of superficial basal cell carcinoma after treatment with imiquimod 5% cream daily for 6 weeks.
Quirk C; Gebauer K; Owens M; Stampone P
Australas J Dermatol; 2006 Nov; 47(4):258-65. PubMed ID: 17034468
[TBL] [Abstract][Full Text] [Related]
35. Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream.
Ezughah FI; Affleck AG; Evans A; Ibbotson SH; Fleming CJ
J Dermatolog Treat; 2008; 19(3):156-8. PubMed ID: 18569271
[TBL] [Abstract][Full Text] [Related]
36. Effect of Methyl Aminolevulinate Photodynamic Therapy With and Without Ablative Fractional Laser Treatment in Patients With Microinvasive Squamous Cell Carcinoma: A Randomized Clinical Trial.
Choi SH; Kim KH; Song KH
JAMA Dermatol; 2017 Mar; 153(3):289-295. PubMed ID: 28199463
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy vs. imiquimod 5% cream as skin cancer preventive strategies in patients with field changes: a randomized intraindividual comparison study.
Sotiriou E; Apalla Z; Vrani F; Lallas A; Chovarda E; Ioannides D
J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):325-329. PubMed ID: 24754529
[TBL] [Abstract][Full Text] [Related]
38. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
Schulze HJ; Cribier B; Requena L; Reifenberger J; Ferrándiz C; Garcia Diez A; Tebbs V; McRae S
Br J Dermatol; 2005 May; 152(5):939-47. PubMed ID: 15888150
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
[TBL] [Abstract][Full Text] [Related]
40. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers.
Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
